Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

What is next, and who is running it?

The next dated milestone on each program. A hollow marker is a registry primary completion date, not a company readout.

Phase 1 on
ClassNone selected
MechanismNone selected

Phase 1 included.

Clear filters

94 of 94 programs on this timeline

202520262027202820292030Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Today

GLP-1 RA 17

SemaglutideApproved
No dated milestone in 2025 to 2030
BeinaglutideStage n/r
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
ExenatidePhase 3
No dated milestone in 2025 to 2030
HDM1002Phase 3
No dated milestone in 2025 to 2030
LiraglutideApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
MazdutidePhase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
TG103Phase 3
No dated milestone in 2025 to 2030
SupaglutidePhase 2/3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

GLP-1/GIP 7

TirzepatideApproved
No dated milestone in 2025 to 2030
VK2735Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
BGM0504Phase 3
No dated milestone in 2025 to 2030
CT-388Phase 3
No dated milestone in 2025 to 2030
HDM1005Phase 3
No dated milestone in 2025 to 2030
RibupatidePhase 3
No dated milestone in 2025 to 2030

GLP-1/glucagon 4

No dated milestone in 2025 to 2030
CotadutidePhase 1
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

GIP/GLP-1/glucagon 2

No dated milestone in 2025 to 2030
UBT251Phase 3
No dated milestone in 2025 to 2030

Amylin combo 1

No dated milestone in 2025 to 2030

Oral small molecule 7

OrforglipronApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
TERN-601Phase 2
No dated milestone in 2025 to 2030
VCT220Phase 3
No dated milestone in 2025 to 2030

GLP-1 conjugate 1

No dated milestone in 2025 to 2030

Amylin 6

No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
ACCG-2671Phase 1/2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
PramlintidePhase 2/3
No dated milestone in 2025 to 2030
ABBV-295Phase 2
No dated milestone in 2025 to 2030

Myostatin/activin 3

No dated milestone in 2025 to 2030
BimagrumabPhase 2
No dated milestone in 2025 to 2030
GaretosmabPhase 2
No dated milestone in 2025 to 2030

MC4R 1

No dated milestone in 2025 to 2030

CB1 2

RimonabantPhase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Lipase inhibitor 1

OrlistatApproved
No dated milestone in 2025 to 2030

Opioid and antidepressant 1

No dated milestone in 2025 to 2030

Sympathomimetic combo 1

No dated milestone in 2025 to 2030

Monoamine reuptake 2

No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

SARM 1

EnobosarmPhase 2
No dated milestone in 2025 to 2030

Class not reported 34

No dated milestone in 2025 to 2030
NimacimabPhase 2
No dated milestone in 2025 to 2030
ARO-ALK7Phase 1/2
No dated milestone in 2025 to 2030
SCO-940/CT-G32Preclinical
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
ASC30Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CT-996Phase 1
No dated milestone in 2025 to 2030
HDM1702Phase 3
No dated milestone in 2025 to 2030
LoxenatidePhase 2/3
No dated milestone in 2025 to 2030
LY4086940Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
VRB-101Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CT-868Phase 2
No dated milestone in 2025 to 2030
DA-1726Phase 1
No dated milestone in 2025 to 2030
HM15211Phase 1
No dated milestone in 2025 to 2030
HS-20094Phase 3
No dated milestone in 2025 to 2030
MET-233IPhase 1/2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
RAY1225Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CetilistatPhase 1
No dated milestone in 2025 to 2030
CRB-913Phase 1
No dated milestone in 2025 to 2030
GUB014295Phase 1
No dated milestone in 2025 to 2030
LB54640Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
VelneperitPhase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
AZD6234Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

MetAP2 inhibitor 1

BeloranibPhase 3
No dated milestone in 2025 to 2030

Serotonin agonist 1

LorcaserinPhase 1/2
No dated milestone in 2025 to 2030

Small molecule 1

MDR-001Phase 3
No dated milestone in 2025 to 2030